当期报告
Notable Labs(NTBL)04-09 00:25
$Notable Labs(NTBL)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-013495 Act: 34 Size: 246 KB 网页链接
简介：Notable Labs, Ltd.于2000年1月27日在以色列成立。公司是一家临床阶段平台治疗公司，为癌症患者开发预测性精准药物。通过其专有的Predictive Precision Medicines Platform（PPMP），Notable Bio-simulates一种癌症治疗方法，旨在预测患者是否可能对这种特定的治疗方法产生反应。Notable的PPMP旨在在患者接受治疗之前识别和选择对临床有反应的患者，从而加快这一患者群体的临床开发。通过不断推进和扩大PPMP在各种疾病和预期医疗结果中的覆盖范围，Notable的目标是成为精准医疗领域的领导者，并彻底改变患者寻求和接受最适合自己的治疗的方式——逐个患者和逐个癌症。Notable认为，与传统药物开发相比，它创建了一种有针对性的、降低风险的授权策略，以更快、更高、更有可能成功的方式提供产品的医疗效果和商业价值。通过改变历史护理标准，Notable旨在为患者和医疗保健社区创造巨大的积极影响。
| 今开：1.07 | 昨收：1.02 |
| 最高：1.16 | 最低：1.04 |
| 涨停价： | 跌停价： |
| 总市值：9378991 |
Notable Labs(NTBL)04-09 00:25
$Notable Labs(NTBL)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-013495 Act: 34 Size: 246 KB 网页链接
Notable Labs(NTBL)04-20 05:05
$Notable Labs(NTBL)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001493152-24-015362 Act: 33 Size: 9 MB 网页链接
Notable Labs(NTBL)04-02 04:35
$Notable Labs(NTBL)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001493152-24-012406 Act: 34 Size: 37 KB 网页链接
Notable Labs(NTBL)04-12 20:55
$Notable Labs(NTBL)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-24-014394 Act: 34 Size: 245 KB 网页链接
Notable Labs(NTBL)05-11 05:15
$Notable Labs(NTBL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-009936 Size: 4 KB 网页链接
Notable Labs(NTBL)05-07 04:35
$Notable Labs(NTBL)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001493152-24-017917 Act: 34 Size: 11 MB 网页链接
Notable Labs(NTBL)05-11 05:15
$Notable Labs(NTBL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-009933 Size: 4 KB 网页链接
Notable Labs(NTBL)05-11 05:25
$Notable Labs(NTBL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-009940 Size: 4 KB 网页链接
Notable Labs(NTBL)04-10 05:25
$Notable Labs(NTBL)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-014100 Act: 34 Size: 255 KB 网页链接
Notable Labs(NTBL)03-25 21:05
$Notable Labs(NTBL)$ 8-K Current report, item 5.07 Accession Number: 0001493152-24-011081 Act: 34 Size: 222 KB 网页链接
$Notable Labs(NTBL)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001493152-24-021999 Act: 34 Size: 10 MB 网页链接
$Notable Labs(NTBL)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-24-019823 Act: 34 Size: 3 MB 网页链接
$Notable Labs(NTBL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-009938 Size: 5 KB 网页链接
$Notable Labs(NTBL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-009940 Size: 4 KB 网页链接
$Notable Labs(NTBL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-009922 Size: 6 KB 网页链接
$Notable Labs(NTBL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-009929 Size: 4 KB 网页链接
$Notable Labs(NTBL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-009931 Size: 4 KB 网页链接
$Notable Labs(NTBL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-009933 Size: 4 KB 网页链接
$Notable Labs(NTBL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-009936 Size: 4 KB 网页链接
$Notable Labs(NTBL)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001493152-24-017917 Act: 34 Size: 11 MB 网页链接